ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB212

Comprehensive Evaluation of Clinical Consequences in Diverse Fistula Elevation Procedures

Session Information

Category: Dialysis

  • 803 Dialysis: Vascular Access

Authors

  • Nanami, Masayoshi, Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Japan
  • Mimura, Yasuyuki, Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Japan
  • Kuma, Akihiro, Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Japan
  • Hasuike, Yukiko, Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Japan
  • Kuragano, Takahiro, Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Japan
Background

Arteriovenous fistula (AVF) superficialization is a recommended alternative autologous vascular access (VA) in patients for whom conventional AVF creation is not possible because of insufficient superficial veins. This procedure utilizes a deeply located vein as an outflow conduit in AVF creation and makes the vein accessible for cannulation. Tunnel transposition (TT) is employed in a standard manner as a superficialization technique. However, TT tends to be exclusively applied to the basilic vein in the upper arm because of anatomical considerations and inherent procedural limitations. We recently reported that elevation transposition can serve as a simplified minimally invasive substitute for TT (Contrib Nephrol. 2019;198:1-11). In AVF superficialization employing elevation transposition (i.e., fistula elevation procedure [FEP]), three potential outflow veins are available in the upper arm: the cephalic, basilic, and brachial veins. This study was performed to comprehensively evaluate the clinical consequences of three valid FEP techniques, ascertain whether they are reasonable alternatives to autologous VA, and determine which, if any, have superior performance.

Methods

The demographic and outcome data of 111 patients who underwent the FEP were retrospectively collected and analyzed. The outcomes of the three fistula techniques were assessed and compared in terms of patency rates, requirements for VA intervention therapy (VAIVT), and complication rates.

Results

The basilic, cephalic, and brachial vein-based FEP was performed in 63.1%, 23.4%, and 13.5% of cases, respectively. The overall cumulative primary and secondary patency rates were 76.2% and 98.2% at 1 year and 70.7% and 97.0% at 2 years, respectively. VAIVT was required in 32.4% of cases, and the patency rates at 1 and 2 years after VAIVT were 65.3% and 62.0%, respectively. There were no significant differences in these patency rates among the three FEP types. Minor complications occurred in only 4.5% of cases.

Conclusion

Our results suggest that the FEP provides three equivalently reliable options to accommodate the deeply located venous anatomy of the upper arm on individual-patient basis. The diversity of the FEP may help to expand the applicability of autologous VA.